Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Senner Christopher J. Director Grant or award · Director Stock Option (Right to Buy) +2,700 2,700
2026-01-02 Senner Christopher J. Director Grant or award · Director Stock Option (Right to Buy) +21,810 21,810
2025-06-04 Senner Christopher J. Director Grant or award · Director Stock Option (Right to Buy) +27,000 27,000
2025-01-02 Senner Christopher J. Director Grant or award · Director Stock Option (right to buy) +35,274 35,274
2024-06-05 Senner Christopher J. Director Grant or award · Employee Stock Option (right to buy) +27,000 27,000
2023-05-24 Senner Christopher J. Director Grant or award · Stock Option (right to buy) +27,000 27,000
2022-06-08 Senner Christopher J. Director Grant or award · Stock Option (right to buy) +27,000 27,000
2021-06-16 Senner Christopher J. Director Grant or award · Stock Option (right to buy) +11,029 11,029
2020-06-08 Senner Christopher J. Director Grant or award · Stock Option (Right to Buy) +11,029 11,029

Page 1 of 1 · 9 trades